1. Tormey DC, Falkson G, Growley J, Falkson HC, Voelkel J, Davis TE: Dibromodulcitol and adriamycin ± tamoxifen in advanced breast cancer. Cancer Clin Trials 5:33–39, 1982
2. Jordan VC: Use of the DMBA-induced rat mammary carcinoma system for the evaluation of tamoxifen treatment as a potential adjuvant therapy. Reviews on Endocrine-related Cancer (October supplement), 1978, pp 49–55
3. Jordan VC, Dix CJ, Allen KE: The effectiveness of longterm tamoxifen treatment in a laboratory model for adjuvant hormone therapy of breast cancer.In Jones SE, Salmon SE (eds): Adjuvant Therapy of Cancer, II. Grune and Stratton, New York, 1979, pp 19–26
4. Brown RR, Bain R, Jordan VC: Determination of tamoxifen and metabolite in human serum by high-performance liquid chromatography with post column fluorescence activation. J Chromat 272:351–358, 1983
5. Tormey DC, Gelman R, Band PR, Sears M, Rosenthal SN, DeWys W, Perlia C, Rice MA: Comparison of induction chemotherapies for metastatic breast cancer: An Eastern Cooperative Oncology Group trial. Cancer 50:1235–1244, 1982